-- MediSwitch Drug Interactions Import (Part 69/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12657, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(12657, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(12657, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(12657, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(12657, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(12657, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(33012, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(33012, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(33012, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(33012, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(33012, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(33012, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(33012, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(33012, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(33012, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(33012, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(33012, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(33012, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(33012, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(33012, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(33012, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(33012, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(33012, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(33012, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(33012, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(33012, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(33012, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(33012, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(33012, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(33012, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(33012, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(33012, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(33012, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33012, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(33012, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(33012, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(33012, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(33012, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(33012, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(33012, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(33012, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(33012, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(33012, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(33012, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(33012, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(33012, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(33012, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(33012, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(33012, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(33012, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(33012, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(33012, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(33012, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(33012, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(33012, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(33012, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(33012, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(33012, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(33012, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(33012, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(33012, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(33012, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(33012, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(33012, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(33012, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(33012, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(33012, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(33012, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(33012, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(33012, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(33012, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(33012, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(33012, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(33012, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(33012, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(33012, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33012, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(33012, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(33012, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(33012, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(33012, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(33012, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(33012, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(33012, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(33012, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(33012, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(33012, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(33012, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(33012, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(33012, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(33012, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(33012, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(33012, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(33012, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(33012, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(33012, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(33012, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(33012, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(13218, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13218, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(13218, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13218, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13218, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13218, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(13218, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13218, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(13218, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(13218, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(13218, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13218, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(13218, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13218, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(13218, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(13218, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(13218, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13218, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(13218, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(13218, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(13218, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(13218, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(13218, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13218, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13218, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(13218, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(13218, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13218, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(13218, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(13218, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13218, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(13218, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(13218, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13218, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13218, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13218, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(13218, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(13218, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(13218, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13218, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(13218, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13218, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13218, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(13218, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13218, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13218, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13218, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13218, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(13218, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13218, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(13218, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(13218, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(13218, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13218, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(13218, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(13218, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(13218, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(13218, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13218, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(13218, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(13218, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13218, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13218, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13218, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13218, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(13218, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(13218, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(13218, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(13218, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13218, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(13218, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(13218, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(13218, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13218, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13218, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(13218, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13218, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(13218, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(13218, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(13218, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13218, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13218, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13218, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13218, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13218, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13218, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13218, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(13218, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(13218, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13218, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(13218, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(13218, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(8208, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(8208, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(8208, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8208, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(8208, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(8208, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(8208, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(8208, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(8208, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(8208, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(8208, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(8208, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(8208, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(8208, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(8208, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(8208, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(8208, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(8208, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(8208, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(8208, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(8208, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(8208, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(8208, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(8208, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8208, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(8208, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(8208, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8208, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(8208, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(8208, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(8208, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(8208, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(8208, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(8208, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(8208, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(8208, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(8208, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(8208, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(8208, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(8208, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(8208, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(8208, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(8208, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(8208, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(8208, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(8208, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(8208, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(8208, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(8208, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(8208, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(8208, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(8208, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(8208, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(8208, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(8208, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(8208, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(8208, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(8208, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(8208, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(8208, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(8208, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(8208, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(8208, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(8208, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(8208, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(8208, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(8208, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(8208, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(8208, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(8208, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(8208, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(8208, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(8208, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(8208, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(8208, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(8208, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(8208, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(8208, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(8208, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8208, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(8208, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(8208, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(8208, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(8208, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(8208, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(8208, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(8208, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(17328, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(17328, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(17328, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(17328, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(17328, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(17328, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(17328, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(17328, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(17328, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(17328, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(17328, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(17328, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(17328, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(17328, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(17328, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(17328, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(17328, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(17328, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(17328, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(17328, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(17328, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(17328, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(17328, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(17328, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(17328, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(17328, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(17328, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(17328, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(17328, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(17328, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(17328, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(17328, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(17328, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(17328, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(17328, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(17328, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(17328, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(17328, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(17328, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(17328, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(17328, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(17328, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(17328, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(17328, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(17328, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(17328, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(17328, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(17328, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(17328, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(17328, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(17328, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(17328, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(17328, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(17328, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(17328, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(17328, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(17328, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(17328, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(17328, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(17328, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(17328, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(17328, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(17328, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(17328, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(17328, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(17328, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(17328, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(17328, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(17328, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(17328, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(17328, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(17328, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(17328, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(17328, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(17328, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(17328, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(17328, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(17328, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(17328, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(17328, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(17328, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(17328, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(17328, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(17328, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(17328, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(17328, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(17328, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(17328, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(17328, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(17328, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(17328, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(17328, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(17328, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(14749, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(14749, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(14749, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14749, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14749, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14749, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(14749, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(14749, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(14749, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(14749, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(14749, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(14749, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(14749, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(14749, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(14749, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(14749, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(14749, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(14749, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(14749, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(14749, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(14749, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(14749, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(14749, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(14749, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(14749, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(14749, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(14749, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(14749, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(14749, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(14749, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14749, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(14749, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(14749, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(14749, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(14749, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(14749, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(14749, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(14749, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(14749, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(14749, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(14749, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(14749, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(14749, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(14749, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14749, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(14749, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(14749, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(14749, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(14749, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(14749, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(14749, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(14749, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(14749, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(14749, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(14749, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(14749, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(14749, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(14749, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(14749, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(14749, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(14749, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(14749, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(14749, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(14749, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(14749, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(14749, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(14749, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(14749, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(14749, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(14749, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(14749, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(14749, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(14749, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(14749, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(14749, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(14749, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(14749, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(14749, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(14749, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(14749, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(14749, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(14749, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(14749, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(14749, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14749, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(14749, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(14749, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(14749, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(14749, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(14749, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(14749, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(14749, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(26766, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(26766, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(26766, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(26766, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(26766, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(26766, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(26766, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(26766, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(26766, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(26766, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(26766, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(26766, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(26766, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(26766, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(26766, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(26766, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(26766, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(26766, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(26766, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(26766, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(26766, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(26766, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(26766, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(26766, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(26766, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(26766, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(26766, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(26766, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(26766, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(26766, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(26766, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(26766, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(26766, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(26766, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(26766, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(26766, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(26766, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(26766, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(26766, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(26766, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(26766, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(26766, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(26766, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(26766, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(26766, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(26766, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(26766, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(26766, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(26766, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(26766, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(26766, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(26766, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(26766, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(26766, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(26766, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(26766, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(26766, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(26766, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(26766, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(26766, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(26766, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(26766, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(26766, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(26766, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(26766, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(26766, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(26766, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(26766, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(26766, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(26766, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(26766, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(26766, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(26766, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(26766, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(26766, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(26766, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(26766, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(26766, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(26766, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(26766, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(26766, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(26766, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(26766, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(26766, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(26766, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(26766, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(26766, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(26766, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(26766, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(26766, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(26766, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(26766, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(26766, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(13686, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13686, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(13686, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13686, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13686, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13686, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(13686, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13686, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(13686, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(13686, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(13686, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13686, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(13686, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13686, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(13686, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(13686, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(13686, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(13686, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(13686, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(13686, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(13686, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(13686, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(13686, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(13686, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13686, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(13686, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(13686, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13686, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(13686, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(13686, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13686, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(13686, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(13686, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13686, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13686, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13686, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(13686, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(13686, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(13686, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(13686, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(13686, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13686, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13686, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(13686, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13686, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(13686, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13686, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13686, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(13686, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(13686, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(13686, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(13686, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(13686, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13686, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(13686, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(13686, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(13686, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(13686, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(13686, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(13686, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(13686, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13686, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13686, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13686, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13686, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(13686, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(13686, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(13686, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(13686, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13686, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(13686, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(13686, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(13686, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13686, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(13686, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(13686, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13686, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(13686, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(13686, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(13686, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13686, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(13686, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(13686, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(13686, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13686, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(13686, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(13686, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(13686, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(13686, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(13686, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(13686, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(13686, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(28228, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(28228, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(28228, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(28228, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28228, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(28228, 'warfarin sodium', 'N/A', 'minor', 'Acetaminophenalcohol†allopurinolaminosalicylic acidamiodarone HClargatrobanaspirinatenololatorvastatin†azithromycinbivalirudincapecitabinecefamandolecefazolincefoperazonecefotetancefoxitinceftriaxonecelecoxibcerivastatinchenodiolchloramphenicolchloral hydrate†chlorpropamidecholestyramine†cimetidineciprofloxacincisaprideclarithromycinclofibratecyclophosphamide†danazoldextrandextrothyroxinediazoxide diclofenacdicumaroldiflunisaldisulfiramdoxycyclineerythromycinesomeprazoleethacrynic acidezetimibefenofibratefenoprofenfluconazolefluorouracilfluoxetineflutamidefluvastatinfluvoxaminegefitinibgemifibrozilglucagonhalothaneheparinibuprofenifosfamideindomethacininfluenza virus vaccineitraconazoleketoprofenketorolaclansoprazolelepirudinlevamisolelevofloxacinlevothyroxineliothyronine lovastatinmefenam', 'DailyMed'),
(28228, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(28228, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(28228, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(28228, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(28228, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(28228, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(28228, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(28228, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(28228, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(28228, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(28228, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(28228, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(28228, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(28228, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(28228, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(28228, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(28228, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(28228, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(28228, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(28228, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(28228, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28228, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(28228, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(28228, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28228, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(28228, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(28228, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(28228, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(28228, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(28228, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(28228, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(28228, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28228, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(28228, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(28228, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(28228, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(28228, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(28228, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(28228, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(28228, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(28228, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(28228, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(28228, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(28228, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(28228, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(28228, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(28228, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(28228, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(28228, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(28228, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(28228, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(28228, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(28228, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(28228, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(28228, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(28228, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(28228, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(28228, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(28228, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(28228, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(28228, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(28228, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(28228, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(28228, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(28228, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(28228, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(28228, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(28228, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(28228, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(28228, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(28228, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(28228, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(28228, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(28228, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(28228, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(28228, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(28228, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(28228, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(28228, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28228, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(28228, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(28228, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(28228, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(28228, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(28228, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(28228, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(28228, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'furosemide', 'N/A', 'minor', 'The intake of furosemide and sucralfate should be separated by at least two hours.One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(25877, 'heparin sodium', 'N/A', 'moderate', 'Platelet inhibitors Drugs such as acetylsalicylic acid, dextran, phenylbutazone, ibuprofen, indomethacin, dipyridamole, hydroxychloroquine and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(25877, 'tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(25877, 'ciprofloxacin hydrochloride', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25877, 'tapentadol hydrochloride', 'N/A', 'major', 'The following substances have been included in a set of interaction studies without any clinically significant finding: acetaminophen, acetylsalicylic acid, naproxen and probenecid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(25877, 'ciprofloxacin', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25877, 'atomxetine hyrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(25877, 'salsalate', 'N/A', 'minor', 'ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO SALSALATE AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS. Drugs and foods that raise urine pH will increase renal clearance and urinary excretion of salicylic acid, thus lowering plasma levels: acidifying drugs or foods will decrease urinary excretion and increase plasma levels.', 'DailyMed'),
(25877, 'adapalene', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with adapalene gel.', 'DailyMed'),
(25877, 'enoxaparin sodium', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(25877, 'aspirin and dipyridamole', 'N/A', 'minor', '7.5 Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(25877, 'pilocarpine hydrochloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(25877, 'atomoxetine hydrochloride', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(25877, 'finasteride', 'N/A', 'major', 'Other Concomitant Therapy: Although specific interaction studies were not performed, finasteride tablets USP was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions.', 'DailyMed'),
(25877, 'balsalazide disodium', 'N/A', 'major', '7 DRUG INTERACTIONS In an in vitro study using human liver microsomes, balsalazide and its metabolites [5-aminosalicylic acid (5-ASA), N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA), 4-aminobenzoyl-ß-alanine (4-ABA) and N-acetyl-4-aminobenzoyl-ß–alanine (N-Ac-4-ABA)] were not shown to inhibit the major CYP enzymes evaluated (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4/5).', 'DailyMed'),
(25877, 'drospirenone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance on temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'norethindrone and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation have been noted when these drugs were administered with combination oral contraceptives.', 'DailyMed'),
(25877, 'ciprofloxacin hydrochloride   tablet', 'N/A', 'minor', 'Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.', 'DailyMed'),
(25877, 'norethindrone acetate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'norgestimate and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'norethindrone and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid, due to induction of conjugation, have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'drug_class', 'N/A', 'minor', 'DRUG INTERACTIONS The following interactions are from a published review and include reports concerning both oral and topical salicylate administration. The relationship of these interactions to the use of SA 6% is not known. I. Due to the competition of salicylate with other drugs for binding to serum albumin the following drug interactions may occur: DRUG DESCRIPTION OF INTERACTION Sulfonylureas Hypoglycemia potentiated. Methotrexate Decreases tubular reabsorption; clinical toxicity from methotrexate can result. Oral Anticoagulants Increased bleeding. II. Drugs changing salicylate levels by altering renal tubular reabsorption: DRUG DESCRIPTION OF INTERACTION Corticosteroids Decreases plasma salicylate level; tapering doses of steroids may promote salicylism. Acidifying Agents Increases p', 'DailyMed'),
(25877, 'nateglinide', 'N/A', 'minor', 'In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding. Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid and tolbutamide in vitro.', 'DailyMed'),
(25877, 'fondaparinux sodium', 'N/A', 'major', '7 DRUG INTERACTIONS In clinical studies performed with ARIXTRA, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium. In addition, ARIXTRA neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.', 'DailyMed'),
(25877, 'etonogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'norethindrone acetate and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'desogestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine and clofibric acid have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12.', 'DailyMed'),
(25877, 'carbidopa, levodopa and entacapone', 'N/A', 'minor', 'Drugs that are highly protein bound (such as warfarin, salicylic acid, phenylbutazone, and diazepam): Levodopa Levodopa is bound to plasma protein only to a minor extent (about 10% to 30%). In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(25877, 'cidofovir', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol', 'N/A', 'minor', 'Decreased plasma concentrations of acetaminophen and increased clearance of temazepam, salicylic acid, morphine, and clofibric acid, due to induction of conjugation (particularly glucuronidation), have been noted when these drugs were administered with oral contraceptives.', 'DailyMed'),
(25877, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(25877, 'gabapentin', 'N/A', 'minor', '7.5 Drug/Laboratory Test Interactions Because false positive readings were reported with the Ames N-Multistix SG®* dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein.', 'DailyMed'),
(25877, 'zinc oxide, menthol, unspecified form, and tretinoin', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid with tretinoin.', 'DailyMed'),
(25877, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25877, 'cyclo/gaba 10/300 pack', 'N/A', 'minor', '7.4 Drug/Laboratory Test Interactions Because false positive readings were reported withthe Ames N-Multistix SG ® dipstick test for urinary protein whengabapentin was added to other antiepileptic drugs, the more specificsulfosalicylic acid precipitation procedure is recommended to determine thepresence of urine protein.', 'DailyMed'),
(25877, 'salicylic acid', 'N/A', 'minor', 'The relationship of these interactions to the use of Salicylic Acid 6% is not known.', 'DailyMed'),
(25877, 'spironolactone', 'N/A', 'minor', 'Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6). 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and acetylsalicylic acid are used concomitantly, spironolactone may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(25877, 'tetracaine hydrochloride and oxymetazoline hydrochloride', 'N/A', 'minor', '7.1 Drugs That May Cause Methemoglobinemia When Used with KOVANAZE Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Oth', 'DailyMed'),
(25877, 'lidocaine and prilocaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'lidocaine', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfa', 'DailyMed'),
(25877, 'lidocaine / prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(25877, 'lidocaine, prilocaine', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(25877, 'aspirin and dipyridamole extended release', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(25877, 'carvedilol', 'N/A', 'major', '7.2 Other Concomitant Therapy Although specific interaction studies were not performed, finasteride was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, H 2 antagonists and quinolone anti-infectives without evidence of clinically significant adverse interactions', 'DailyMed'),
(25877, 'articaine hydrochloride and epinephrine bitartrate', 'N/A', 'severe', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Table 5: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, sulfasalazin', 'DailyMed'),
(25877, 'bupivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'mepivacaine hydrochloride', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'bupivacaine hcl collagen-matrix', 'N/A', 'minor', '7.2 Drugs Associated with Methemoglobinemia Patients who are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, m', 'DailyMed'),
(25877, 'norethindrone acetate/ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'atomoxetine', 'N/A', 'minor', 'Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin.', 'DailyMed'),
(25877, 'lidocaine hydrochloride', 'N/A', 'minor', 'Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastics Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sul', 'DailyMed'),
(25877, 'dapsone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(25877, 'cidofovir anhydrous', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(25877, 'prilocaine hydrochloride', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(25877, 'norethindrone and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(25877, 'entacapone', 'N/A', 'minor', 'In vitro studies have shown no binding displacement between entacapone and other highly bound drugs, such as warfarin, salicylic acid, phenylbutazone, and diazepam.', 'DailyMed'),
(25877, 'benzocaine, butamben, and tetracaine hydrochloride', 'N/A', 'minor', 'DRUG INTERACTIONS Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(25877, 'norgestrel and ethinyl estradiol', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(25877, 'norelgestromin and ethinyl estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'ropivacaine hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics [see Warnings and Precautions (5.4)]: Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine,prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetami', 'DailyMed'),
(25877, 'tetracaine hcl', 'N/A', 'minor', 'Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agents cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs Acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(25877, 'bupivacaine', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'norethindrone acetate and ethinyl estradiol, and ferrous fumarate', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'lidocaine patch 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs', 'DailyMed'),
(25877, 'levonorgestrel/ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'furosemide, benzalkonium chloride', 'N/A', 'minor', 'One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency.', 'DailyMed'),
(25877, 'spironolactone and hydrochlorothiazide', 'N/A', 'minor', 'Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone. Therefore, when spironolactone and hydrochlorothiazide tablets and acetylsalicylic acid are used concomitantly, spironolactone and hydrochlorothiazide tablets may need to be titrated to higher maintenance dose and the patient should be observed closely to determine if the desired effect is obtained.', 'DailyMed'),
(25877, 'daspone', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of dapsone gel, 7.5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para‐aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(25877, 'pilocarpine hydrchloride', 'N/A', 'minor', 'While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sjogren''s efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.', 'DailyMed'),
(25877, 'levonorgestrel / ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'carospir', 'N/A', 'severe', '7 DRUG INTERACTIONS Agents increasing serum potassium: Concomitant administration can lead to hyperkalemia (5.1, 7.1) Lithium: Increased risk of lithium toxicity (7.2) NSAIDs: May reduce the diuretic, natriuretic and antihypertensive effect of CAROSPIR (7.3) Digoxin: CAROSPIR can interfere with radioimmunologic assays of digoxin exposure (7.4) Cholestyramine: Hyperkalemic metabolic acidosis has been reported with concomitant use (7.5) Acetylsalicylic Acid (ASA): ASA may reduce the efficacy of spironolactone (7.6) 7.1 Drugs and Supplements Increasing Serum Potassium Concomitant administration of CAROSPIR with potassium supplementation or drugs that can increase potassium may lead to severe hyperkalemia. 7.6 Acetylsalicylic Acid Acetylsalicylic acid may reduce the efficacy of spironolactone.', 'DailyMed'),
(25877, 'levonorgestrel / ethinyl estradiol and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'adapalene topical solution', 'N/A', 'moderate', 'Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with Adapalene Topical Solution 0.1%.', 'DailyMed'),
(25877, 'salicylic acid 10%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(25877, 'cidofovir dihydrate', 'N/A', 'minor', 'Drug Interactions Probenecid Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).', 'DailyMed'),
(25877, 'lidocaine and capsaicin', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites(nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics(benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents(cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics(dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials(chloroquine, primaquine) Anticonvulsants(Phenobarbital, phenytoin, sodium valproate) Other Drugs(acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(25877, 'mesalamine', 'N/A', 'minor', '7.3 Interference With Urinary Normetanephrine Measurements Use of mesalamine may lead to spuriously elevated test results when measuring urinary normetanephrine by liquid chromatography with electrochemical detection, because of the similarity in the chromatograms of normetanephrine and mesalamine''s main metabolite, N-acetylaminosalicylic acid.', 'DailyMed'),
(25877, 'norelgestromin and ethinly estradiol', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'asprin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(25877, 'aspirin and extended-release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(25877, 'heparin sodium in sodium chloride', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including salicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIb/IIIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(25877, 'lidocaine hydrochloride and hydrocortisone acetate', 'N/A', 'minor', 'DRUG INTERACTIONS: Patients that are administered local anesthetics may be at increased risk of developing methemoglobinemia when concurrently exposed to the following oxidizing agents: ​CLASS ​EXAMPLES Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local Anesthetics benzocaine, lidocaine, bupivacaine, mepivacaine, tetracaine, prilocaine, procaine, articaine, ropivacaine Antineoplastic agent cyclophosphamide, flutamide, rasburicase, ifosfamide, hydroxyurea Antibiotics dapsone, sulfonamides, nitrofurantoin, para-aminosalicylic acid Antimalarials chloroquine, primaquine Anticonvulsants phenytoin, sodium valproate, phenobarbital Other drugs acetaminophen, metoclopramide, sulfa drugs (i.e., sulfasalazine), quinine', 'DailyMed'),
(25877, 'bupivacaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., MARCAINE WITH EPINEPHRINE) are used in patients ', 'DailyMed'),
(25877, 'lidocaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'lidocaine hydrochloride and epinephrine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'articaine hydrochloride and epinephrine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(25877, 'prilocaine hcl and epinephrine', 'N/A', 'severe', 'Clinically Significant Drug Interactions Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: EXAMPLES OF DRUGS ASSOCIATED WITH METHEMOGLOBINEMIA: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic Agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metocl', 'DailyMed'),
(25877, 'trubrexa patch er', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Nitrates/Nitrites (nitric oxide, nitroglycerin, nitroprusside, nitrous oxide) Local anesthetics (benzocaine, bupivacaine, lidocaine, prilocaine, procaine, tetracaine) Antineoplastic Agents (cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase) Antibiotics (dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides) Antimalarials (chloroquine, primaquine) Anticonvulsants (Phenobarbital, phenytoin, sodium valproate) Other Drugs (acetaminophen, metoclopramide, quinine, sulfasalazine)', 'DailyMed'),
(25877, 'norethindrone and ethinyl estradiol and ferrous fumarate tablet', 'N/A', 'minor', 'COCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(25877, 'penicillin g benzathine and penicillin g procaine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitroglycerin, nitroprusside, nitric oxide, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'lidocaine 5%', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with Lidocaine Patch 5% Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate O', 'DailyMed'),
(25877, 'etonogestrel and ethinyl estradiol vaginal', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(25877, 'etonogestrel and ethinyl estradiol vaginal ring', 'N/A', 'minor', 'CHCs have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid and temazepam.', 'DailyMed'),
(25877, 'ciprofolxacin', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(25877, 'heparin sodium and dextrose', 'N/A', 'moderate', '7.2 Platelet Inhibitors Drugs such as NSAIDS (including acetylsalicylic acid, ibuprofen, indomethacin, and celecoxib), dextran, phenylbutazone, thienopyridines, dipyridamole, hydroxychloroquine, glycoprotein IIv/IIa antagonists (including abciximab, eptifibatide, and tirofiban), and others that interfere with platelet-aggregation reactions (the main hemostatic defense of heparinized patients) may induce bleeding and should be used with caution in patients receiving heparin sodium.', 'DailyMed'),
(25877, 'bupivacaine hydrochloride, lidocaine hydrochloride, triamcinolone acetonide, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'marcaine, lidocaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, sodium chloride, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'ketorolac tromethamine, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'triamcinolone acetonide, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'dexamethasone sodium phosphate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'betamethasone sodium phosphate, betamethasone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'marcaine, kenalog, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'methylprednisolone acetate, lidocaine hydrochloride, bupivacaine hydrochloride, povidine iodine, isopropyl alcohol', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'dexamethasone sodium phosphate, lidocaine hydrochloride, maricaine, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'enoxaparin sodium, isopropyl alcohol', 'N/A', 'minor', 'These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.', 'DailyMed'),
(25877, 'bupivacaine hydrochloride and epinephrine bitartrate', 'N/A', 'minor', 'Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'betamethasone sodium phosphate and betamethasone acetate, bupivacaine hydrochloride, povidine iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine (e.g., Bupivacaine Hydrochloride and Epinephrine Injecti', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol and ferrous fumarate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(25877, 'bupivacaine hydrochloride in dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'methylprednisolone acetate, bupivacaine hydrochloride, povidone-iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'lidocaine hydrochloride monohydrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate, Other drugs acetaminophen, metoclopramide, quinine, s', 'DailyMed'),
(25877, 'articaine hydrochloride, epinephrine bitartrate', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, ropivacaine, procaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine Monoamine Oxidase Inhibitors, Nonselective Beta-Adrenergic Antagonists, or Tricyclic Antidepressants: May produce severe, prolonged hypertension (7) Phenothiazines and Butyrophenones: May reduce or reverse', 'DailyMed'),
(25877, 'lidocaine, isopropyl alcohol', 'N/A', 'minor', 'Drugs That May Cause Methemoglobinemia When Used with LIDOCAN™ Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia: Class Example Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants Phenobarbital, phenytoin, sodium valproate Other drugs ', 'DailyMed'),
(25877, 'ciprofloxacin tablets', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(25877, 'ciprofloxacin hcl', 'N/A', 'moderate', 'NSAIDs Use with caution Non-steroidal anti-inflammatory drugs (but not acetyl salicylic acid) in combination of very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies and in postmarketing.', 'DailyMed'),
(25877, 'aspirin and extended - release dipyridamole', 'N/A', 'minor', 'Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels.', 'DailyMed'),
(25877, 'marcaine, lidocaine, povidone iodine', 'N/A', 'severe', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.6 Potent Inhalation Anesthetics Serious dose-related cardiac arrhythmias may occur if preparations containing a vasoconstrictor such as epinephrine are used in patients during or following the administra', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol and ferrous bisglycinate', 'N/A', 'minor', 'Combined oral contraceptives have been shown to decrease plasma concentrations of acetaminophen, clofibric acid, morphine, salicylic acid, temazepam and lamotrigine.', 'DailyMed'),
(25877, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'levonorgestrel and ethinyl estradiol and ethinyl estradiol tablets', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of COCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'vortioxetine', 'N/A', 'major', 'Coadministration of aspirin 150 mg/day with multiple daily doses of TRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(25877, 'segesterone acetate and ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(25877, 'bupivacaine hydrochloride with dextrose', 'N/A', 'minor', 'Examples of Drugs Associated with Methemoglobinemia: Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, isofamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine', 'DailyMed'),
(25877, 'bupivacaine and meloxicam', 'N/A', 'major', 'Examples of Drugs Associated with Methemoglobinemia Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea, ifosfamide, rasburicase Antibiotics dapsone, nitrofurantoin, para-aminosalicylic acid, sulfonamides Antimalarials chloroquine, primaquine Anticonvulsants phenobarbital, phenytoin, sodium valproate Other drugs acetaminophen, metoclopramide, quinine, sulfasalazine 7.2 Meloxicam Drug Interactions See Table 6 for clinically significant drug interactions with meloxicam.', 'DailyMed'),
(25877, 'salicylic acid 5.9%', 'N/A', 'minor', 'The relationship of these interactions to the use of SALICYLIC ACID is not known.', 'DailyMed'),
(25877, 'dapsone gel, 5%', 'N/A', 'moderate', '7.4 Concomitant Use with Drugs that Induce Methemoglobinemia Concomitant use of Dapsone Gel, 5% with drugs that induce methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbital, phenytoin, primaquine, and quinine may increase the risk for developing methemoglobinemia [see Warnings and Precautions (5.1)].', 'DailyMed'),
(25877, 'remibrutinib', 'N/A', 'minor', 'Use of the antiplatelet agents, acetyl salicylic acid at doses up to 100 mg daily or clopidogrel up to 75 mg daily, was allowed in the RHAPSIDO clinical studies.', 'DailyMed'),
(25877, 'sucroferric oxyhydroxide', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 1 Oral drugs that can be administered concomitantly with Velphoro Calcitriol Ciprofloxacin Digoxin Enalapril Furosemide HMG-CoA reductase inhibitors Hydrochlorothiazide Losartan Metoprolol Nifedipine Omeprazole Quinidine Warfarin Oral drugs that are to be separated from Velphoro Dosing Recommendations Doxycycline Acetylsalicylic acid Cephalexin Take at least 1 hour before Velphoro. ( 7) Take acetylsalicylic acid, cephalexin and doxycycline at least 1 hour before Velphoro.', 'DailyMed'),
(25877, 'levonorgestrel/ethinyl estradiol', 'N/A', 'minor', 'Other Drugs Clinical effect Concomitant use of CHCs may decrease systemic exposure of acetaminophen, morphine, salicylic acid, and temazepam.', 'DailyMed'),
(7572, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(7572, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(7572, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12271, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12271, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12271, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(7019, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(7019, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(7019, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12268, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12268, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12268, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(14113, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(14113, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(14113, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(22414, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(22414, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(22414, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(4047, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(4047, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4047, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(18513, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(18513, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(18513, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12298, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12298, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12298, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(8094, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(8094, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(8094, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29222, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29222, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29222, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10445, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10445, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10445, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(27525, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(27525, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(27525, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(32127, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(32127, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(32127, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(3656, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(3656, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(3656, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(4345, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(4345, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4345, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12266, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12266, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12266, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29305, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29305, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29305, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29210, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29210, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29210, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26556, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26556, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26556, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(6756, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(6756, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(6756, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(24912, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(24912, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(24912, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12336, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12336, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12336, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(6758, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(6758, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(6758, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(13601, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(13601, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13601, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26962, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26962, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26962, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29398, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29398, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29398, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(23420, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(23420, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(23420, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(30424, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(30424, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(30424, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(18759, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(18759, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(18759, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10448, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10448, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10448, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12135, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12135, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12135, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(8497, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(8497, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(8497, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(18058, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(18058, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(18058, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26985, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26985, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26985, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10442, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10442, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10442, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(23416, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(23416, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(23416, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(6812, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(6812, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(6812, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(1715, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(1715, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(1715, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12253, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12253, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12253, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(23417, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(23417, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(23417, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(4702, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(4702, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4702, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29208, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29208, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29208, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(4603, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(4603, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4603, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26963, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26963, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26963, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(7573, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(7573, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(7573, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(33250, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(33250, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(33250, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12264, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12264, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12264, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12299, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12299, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12299, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10799, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10799, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10799, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(24262, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(24262, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(24262, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10449, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10449, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10449, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(12272, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(12272, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12272, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29303, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29303, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29303, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26957, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26957, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26957, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(26959, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(26959, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(26959, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10298, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10298, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10298, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(9340, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(9340, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(9340, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(8565, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(8565, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(8565, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(25917, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(25917, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(25917, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(32121, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(32121, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(32121, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29227, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29227, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29227, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(19262, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(19262, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(19262, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(5741, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(5741, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(5741, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(32147, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(32147, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(32147, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29209, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29209, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29209, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(10447, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(10447, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10447, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(4701, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(4701, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4701, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(29295, 'doxazosin', 'N/A', 'minor', 'In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy.', 'DailyMed'),
(29295, 'amlodipine', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29295, 'drug_class', 'N/A', 'contraindicated', '7.1 Nitrates Administration of sildenafil tablets with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, sildenafil tablets were shown to potentiate the hypotensive effects of nitrates [see Dosage and Administration (2.3), Contraindications (4.1), Clinical Pharmacology (12.2)].', 'DailyMed'),
(19413, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(28190, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(7699, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(4505, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(23164, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(29494, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(1938, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(25346, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(883, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(23049, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(20253, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(2984, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(14881, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(32795, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(19414, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(11012, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(25724, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(29493, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(33324, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(25423, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(7344, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(33131, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(4638, 'drug_class', 'N/A', 'moderate', '7 DRUG INTERACTIONS Statins: Caution should be used when prescribing niacin with statins as these agents can increase risk of myopathy/rhabdomyolysis.(5.1,7.1) Bile Acid Sequestrants: Bile acid sequestrants have a high niacin-binding capacity and should be taken at least 4 - 6 hours before NIASPAN administration. (7.2) 7.1 Statins Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily. [see Warnings and Precautions (5) and Clinical Pharmacology (12.3)]. 7.2 Bile Acid Sequestrants An in vitro study results suggest that the bile acid-binding resins have high', 'DailyMed'),
(359, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(359, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(359, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(359, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(16021, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(16021, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(16021, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16021, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16021, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(16021, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16021, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(16021, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13438, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13438, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13438, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18246, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18246, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18246, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18246, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18246, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18246, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18246, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18246, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32900, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32900, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32900, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32900, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32900, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32900, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32900, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32900, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11377, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11377, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11377, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11377, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11377, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11377, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11377, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11377, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(26244, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(26244, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(26244, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(26244, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32832, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32832, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32832, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32832, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32832, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(32832, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32832, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32832, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(25653, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25653, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25653, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25653, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25653, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25653, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25653, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25653, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7699, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7699, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7699, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7699, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7699, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7699, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7699, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7699, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3277, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3277, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3277, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3277, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3277, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3277, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3277, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3277, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(10502, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10502, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(10502, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10502, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5421, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5421, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5421, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5421, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28550, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28550, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28550, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28550, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2410, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2410, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2410, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2410, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32863, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32863, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32863, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32863, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32863, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32863, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32863, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32863, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(17721, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17721, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(17721, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17721, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15454, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15454, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15454, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15454, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15454, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15454, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15454, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15454, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(19264, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19264, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(19264, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19264, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(22597, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22597, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22597, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22597, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23851, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23851, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23851, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23851, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23851, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23851, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23851, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23851, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7491, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7491, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7491, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7491, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7491, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7491, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7491, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7491, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8308, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8308, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8308, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3837, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3837, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3837, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3837, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3837, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3837, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3837, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3837, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30701, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30701, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(30701, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5245, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5245, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5245, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5245, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5245, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5245, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5245, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5245, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32207, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32207, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32207, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31763, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31763, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31763, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8156, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8156, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8156, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8156, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8156, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8156, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8156, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8156, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8973, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8973, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8973, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8973, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8973, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8973, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(962, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(962, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(962, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(962, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(962, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(962, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(962, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(962, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15600, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15600, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15600, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15600, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15600, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15600, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15600, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15600, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4670, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4670, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4670, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4670, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4670, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4670, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4670, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4670, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32139, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32139, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32139, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32139, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32139, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32139, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32139, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32139, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4864, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4864, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4864, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4864, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4864, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4864, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4864, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4864, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12419, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12419, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12419, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1713, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1713, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1713, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1713, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1713, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1713, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1713, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1713, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12420, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12420, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12420, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12420, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12420, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12420, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(164, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(164, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(164, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(164, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(164, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(164, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(164, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(164, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8222, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8222, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8222, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33105, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33105, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33105, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(33105, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33105, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33105, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33105, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33105, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6708, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6708, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6708, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8250, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8250, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8250, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8250, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8250, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8250, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31833, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31833, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31833, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1762, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1762, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1762, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1762, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29494, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29494, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29494, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29494, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29494, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29494, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29494, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29494, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(19004, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19004, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(19004, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19004, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32868, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32868, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32868, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27439, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(27439, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(27439, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27439, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(27439, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(27439, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27439, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(27439, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(17562, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17562, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(17562, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17562, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20314, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20314, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20314, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20314, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24357, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(24357, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(24357, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24357, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24357, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24357, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24357, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24357, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7695, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7695, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7695, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7695, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7695, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7695, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6004, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6004, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6004, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6004, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6004, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6004, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6004, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6004, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32810, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32810, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32810, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32810, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4863, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4863, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4863, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4863, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4863, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4863, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4863, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4863, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28091, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28091, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28091, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28091, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28091, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28091, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28091, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28091, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28786, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28786, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28786, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28786, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28786, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28786, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28786, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28786, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20968, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20968, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20968, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20968, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(19480, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19480, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(19480, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19480, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4061, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4061, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4061, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4061, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4061, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4061, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30941, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30941, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30941, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29492, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29492, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29492, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29492, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4803, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4803, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4803, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4803, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4803, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4803, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6790, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6790, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6790, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6790, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6790, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6790, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6790, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6790, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2949, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(2949, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2949, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(2949, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2949, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2949, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32116, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32116, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32116, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32116, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8223, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8223, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8223, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3530, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3530, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3530, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3530, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11309, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11309, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11309, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11309, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33269, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33269, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33269, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33269, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33269, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33269, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33269, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33269, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7395, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7395, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7395, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31022, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31022, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31022, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31022, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(21051, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21051, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(21051, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31514, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31514, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31514, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5829, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5829, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5829, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5829, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3343, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3343, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3343, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3343, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3343, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3343, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3343, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3343, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(22177, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22177, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22177, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22177, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22177, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22177, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22177, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22177, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24227, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(24227, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(24227, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24227, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24227, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24227, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24227, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24227, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30758, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30758, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30758, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30758, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30758, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30758, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30758, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30758, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20974, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(20974, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20974, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(20974, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20974, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20974, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32235, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32235, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32235, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32235, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32235, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32235, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32235, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32235, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20302, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(20302, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(20302, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20302, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(20302, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20302, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20302, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(20302, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33361, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33361, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33361, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33361, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30703, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30703, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30703, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30703, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30703, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30703, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30703, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30703, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7507, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7507, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7507, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7507, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7507, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7507, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7507, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7507, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30538, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30538, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30538, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30538, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33092, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33092, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33092, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33092, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33092, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33092, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33092, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33092, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(25226, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25226, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25226, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10299, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10299, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(10299, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10299, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12153, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12153, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12153, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12153, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12153, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12153, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32474, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32474, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32474, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7567, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7567, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7567, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7567, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7567, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7567, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7567, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7567, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8227, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8227, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8227, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8227, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8227, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8227, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1938, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1938, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1938, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1938, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1938, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1938, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32698, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32698, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32698, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32698, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5906, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5906, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5906, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5906, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5906, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5906, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5906, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5906, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30832, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30832, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30832, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30832, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(27703, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(27703, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(27703, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27703, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(27703, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(27703, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27703, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(27703, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(883, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(883, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(883, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(883, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(883, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(883, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6559, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6559, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6559, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6559, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6559, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6559, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6559, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6559, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3110, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3110, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3110, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3110, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3110, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3110, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3110, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3110, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13852, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13852, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13852, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13852, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(13852, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13852, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13852, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(13852, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31825, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31825, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31825, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31825, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31825, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31825, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31825, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31825, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32848, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32848, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32848, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32848, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32848, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32848, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14968, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(14968, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(14968, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14968, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14968, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14968, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14968, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14968, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(22045, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22045, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22045, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22658, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22658, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22658, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22658, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22658, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22658, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22658, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22658, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13569, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13569, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13569, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13569, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(1341, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1341, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1341, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1341, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(1341, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1341, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1341, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1341, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3539, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3539, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3539, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3539, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8764, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8764, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8764, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8764, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5872, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5872, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5872, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5872, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4560, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4560, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4560, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20342, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(20342, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(20342, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20342, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(20342, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20342, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20342, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(20342, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(25705, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25705, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25705, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25449, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25449, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25449, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25449, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24693, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24693, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24693, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24693, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3823, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3823, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3823, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3823, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3823, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3823, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3823, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3823, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28114, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28114, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28114, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28114, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(1912, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1912, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1912, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1912, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1912, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1912, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1912, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1912, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(21526, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21526, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(21526, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21526, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(19253, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19253, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(19253, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31252, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31252, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31252, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31252, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31252, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31252, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32679, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32679, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32679, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32679, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32679, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32679, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32679, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32679, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33551, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33551, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33551, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12155, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12155, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12155, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12155, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(22804, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22804, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22804, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22804, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15318, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15318, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15318, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15318, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2904, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2904, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2904, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6849, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6849, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6849, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(6849, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31477, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31477, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31477, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31477, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31477, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31477, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31477, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31477, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4421, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4421, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4421, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4421, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4421, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4421, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4421, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4421, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13545, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13545, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(13545, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13545, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(13545, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13545, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13545, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(13545, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23966, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23966, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23966, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23966, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23966, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23966, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9351, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9351, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9351, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9351, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9351, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9351, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9351, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9351, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11720, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11720, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11720, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11720, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11720, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11720, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11720, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11720, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5992, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5992, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5992, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5992, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23593, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23593, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23593, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23593, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23593, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23593, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9595, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9595, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9595, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9595, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(26482, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(26482, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(26482, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16173, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16173, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(16173, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20967, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20967, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20967, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20967, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24361, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(24361, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24361, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(24361, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24361, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24361, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(21950, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21950, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(21950, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21950, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29452, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29452, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29452, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29452, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29452, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29452, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29452, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29452, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28547, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28547, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28547, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31057, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31057, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31057, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31214, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(31214, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31214, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(31214, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31214, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(31214, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9548, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9548, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9548, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9548, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9548, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9548, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9548, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9548, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33267, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33267, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33267, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33267, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(16509, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(16509, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(16509, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25606, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25606, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25606, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25606, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11646, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11646, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11646, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11646, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11646, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11646, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11646, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11646, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(14884, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(14884, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14884, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(14884, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14884, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14884, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3473, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3473, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3473, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2004, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2004, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2004, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32561, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32561, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32561, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32561, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32561, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32561, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32561, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32561, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(705, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(705, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(705, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(705, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33491, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33491, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33491, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33491, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(1155, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1155, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1155, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1155, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(17738, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17738, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(17738, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7208, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7208, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7208, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7208, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7208, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7208, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7208, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7208, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(10778, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10778, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(10778, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10778, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8336, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8336, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8336, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15686, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15686, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15686, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15686, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15686, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15686, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15686, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15686, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13110, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13110, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13110, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13110, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32627, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32627, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32627, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32627, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(165, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(165, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(165, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(165, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(165, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(165, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(165, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(165, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33449, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33449, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33449, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33449, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33449, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33449, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33449, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33449, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33552, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33552, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33552, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2056, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(2056, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2056, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(2056, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2056, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2056, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33874, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33874, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33874, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33874, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33874, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33874, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33874, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33874, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8844, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8844, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8844, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8844, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(26338, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(26338, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(26338, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7557, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7557, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7557, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7557, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13197, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13197, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13197, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13197, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(17559, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(17559, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(17559, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17559, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(17559, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(17559, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17559, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(17559, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5176, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5176, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5176, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5176, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5176, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5176, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5176, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5176, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29554, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29554, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29554, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29554, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29554, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29554, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29554, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29554, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6533, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6533, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6533, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5193, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5193, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5193, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5193, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32861, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32861, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32861, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32861, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32861, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32861, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32861, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32861, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3897, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3897, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3897, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22889, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22889, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22889, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32847, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(32847, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32847, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32847, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32847, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32847, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7404, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7404, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7404, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7404, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7404, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7404, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29515, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29515, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29515, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29515, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29515, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29515, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29515, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29515, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(14086, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14086, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14086, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14086, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4190, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4190, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4190, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4190, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4190, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4190, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4190, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4190, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15172, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15172, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(15172, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15172, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15172, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15172, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15172, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(15172, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6142, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6142, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6142, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6142, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6142, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6142, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6142, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6142, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29443, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29443, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29443, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7209, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7209, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7209, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7209, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7209, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7209, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7209, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7209, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(18000, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18000, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18000, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18000, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6277, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6277, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6277, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6277, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31346, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31346, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31346, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4319, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4319, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4319, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4319, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4319, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4319, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4319, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4319, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3043, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3043, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3043, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13331, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13331, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13331, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13331, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33085, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33085, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33085, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33085, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33085, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33085, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33085, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33085, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23435, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23435, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23435, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23435, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(10368, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(10368, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(10368, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33005, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33005, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33005, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33005, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32277, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32277, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32277, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32277, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32327, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32327, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32327, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5870, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5870, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(5870, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5870, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31672, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31672, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31672, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31672, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12091, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12091, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12091, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12091, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12091, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12091, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12091, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12091, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30920, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30920, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30920, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30920, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30920, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30920, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30920, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30920, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8748, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8748, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8748, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8748, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8748, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8748, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8748, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8748, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20971, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20971, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20971, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20971, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(18579, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18579, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(18579, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18579, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18579, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18579, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18579, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(18579, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6007, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6007, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6007, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6007, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6007, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6007, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6007, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6007, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15993, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15993, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15993, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15993, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13350, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13350, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13350, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13350, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(20972, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20972, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(20972, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(20972, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6948, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6948, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6948, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6948, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6948, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6948, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6948, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6948, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30540, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30540, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30540, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30540, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8267, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8267, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8267, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8267, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(26924, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(26924, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(26924, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1346, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1346, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1346, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1346, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1346, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1346, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1346, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1346, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3932, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3932, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3932, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3932, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3932, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3932, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3932, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3932, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(3106, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3106, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3106, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(3276, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3276, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3276, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3276, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3276, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3276, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3276, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(3276, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32328, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32328, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32328, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32328, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(9149, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9149, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9149, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9149, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9149, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9149, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9149, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9149, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23480, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23480, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23480, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23480, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23480, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23480, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23480, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23480, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31056, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31056, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31056, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31056, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(30557, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30557, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30557, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30557, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(9873, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9873, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(9873, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9873, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9873, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(9873, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(9873, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(9873, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(12397, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12397, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(12397, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12397, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12397, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(12397, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(12397, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(12397, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(17220, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(17220, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(17220, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25031, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25031, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(25031, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25031, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25031, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(25031, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(25031, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(25031, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(18987, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18987, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18987, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3586, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3586, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(3586, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28557, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28557, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28557, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28557, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28557, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28557, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28557, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28557, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33002, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(33002, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33002, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(33002, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33002, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33002, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6337, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6337, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6337, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6337, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6337, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6337, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6157, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6157, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6157, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6157, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6157, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6157, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6157, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6157, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2754, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(2754, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2754, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(2754, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2754, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2754, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(32724, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32724, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32724, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32724, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6003, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6003, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(6003, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6003, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6003, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6003, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6003, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(6003, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(19009, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(19009, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(19009, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14764, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(14764, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(14764, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1859, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1859, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(1859, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1859, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1859, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1859, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1859, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(1859, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(5325, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5325, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(5325, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5325, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5325, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(5325, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(5325, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(5325, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(27497, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(27497, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(27497, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22454, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22454, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(22454, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22454, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22454, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(22454, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(22454, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(22454, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4134, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4134, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(4134, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4134, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4134, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4134, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4134, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(4134, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6198, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6198, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6198, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7639, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7639, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7639, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7639, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7639, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7639, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7639, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7639, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(1240, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1240, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1240, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1240, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7709, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7709, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(7709, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7709, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7709, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7709, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7709, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(7709, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(32136, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32136, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(32136, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(32136, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(24079, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24079, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(24079, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(24079, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(2372, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2372, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(2372, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(2372, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11645, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11645, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11645, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11645, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(29493, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29493, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29493, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29493, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29493, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29493, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29493, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29493, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(23457, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23457, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(23457, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23457, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23457, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(23457, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(23457, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(23457, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(11381, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11381, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(11381, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11381, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11381, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(11381, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(11381, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(11381, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(21525, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21525, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(21525, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(21525, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(15436, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15436, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(15436, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(15436, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(1414, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(1414, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(1414, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30983, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30983, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(30983, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30983, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30983, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(30983, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(30983, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(30983, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(18212, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18212, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(18212, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(18212, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(7643, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7643, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(7643, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(7643, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(4839, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(4839, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(4839, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29571, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29571, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(29571, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29571, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29571, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(29571, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(29571, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(29571, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(13941, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13941, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(13941, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(13941, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(28806, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28806, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(28806, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28806, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28806, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(28806, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(28806, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(28806, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(33268, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33268, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(33268, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(33268, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8850, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8850, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8850, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8850, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8850, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8850, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8850, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8850, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(6450, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6450, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(6450, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(6450, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(8763, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8763, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(8763, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8763, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8763, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(8763, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(8763, 'multiple vitamins injection', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-Administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed'),
(8763, 'levoketoconazole', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Consult approved product labeling for drugs that are substrates of CYP3A4, P-gp, OCT2, and MATE prior to initiating RECORLEV ( 7.1) Sensitive CYP3A4 or CYP3A4 and P-gp Substrates: Concomitant use of RECORLEV with these substrates is contraindicated or not recommended ( 7.1) Atorvastatin: Use lowest atorvastatin dose possible and monitor for adverse reactions for dosages exceeding 20 mg daily ( 7.1) Metformin: Monitor glycemia, kidney function, and vitamin B12 and adjust metformin dosage as needed ( 7.1) Strong CYP3A4 Inhibitors or Inducers: Avoid use of these drugs 2 weeks before and during RECORLEV treatment ( 7.2) Gastric Acid Modulators: See Full Prescribing Information for recommendations regarding concomitant use with RECORLEV ( 7.2) 7.1 Effect of RECORLEV on Other', 'DailyMed'),
(31455, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(31455, 'rifapentine', 'N/A', 'minor', '7.6 Interactions with Laboratory Tests Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.', 'DailyMed'),
(31455, 'drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3380, 'folic acid, ferrous fumarate, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, zinc oxide, cupric sulfate anhydrous, and selenomethionine', 'N/A', 'minor', 'Drugs which may interact with vitamin B12: Antibiotics, cholestyramine, colchicines, colestipol, metformin, para-aminosalicylic acid, and potassium chloride may decrease the absorption of vitamin B12. Nitrous oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3380, 'methaver', 'N/A', 'minor', 'Drug s which may interact with vitamin B12:• Antibiotic, cholestyramine, colchicines, colestipol, metformin, para-amino salicylic acid, and potassium chloride may decrease the absorption of vitamin B12.• Nitro us oxide can produce a functional vitamin B12 deficiency.', 'DailyMed'),
(3380, 'drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium', 'N/A', 'minor', 'Folates may mask vitamin B12 deficiency.', 'DailyMed'),
(3380, 'ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin', 'N/A', 'minor', '• Phenytoin: May decrease folic acid concentrations (7.2) • Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited (7.2) 7.1 Drug Interactions Affecting Co-administered Drugs Warfarin: Vitamin K, a component of INFUVITE ADULT, antagonizes the anticoagulant action of warfarin. Chloramphenicol: In patients with pernicious anemia, the hematologic response to vitamin B12 therapy may be inhibited by chloramphenicol.', 'DailyMed');

